Ransomware victim disclosure
← All victimsCytek Biosciences
Claimed by cmdorganization · listed 19 days ago
Status timeline
- Listed
May 2, 2026
- Data leaked
At a glance
- Group
- cmdorganization
- Status
- Data leaked
- Country
- US
- Sector
- Healthcare
- Listed on leak site
- May 2, 2026
About the victim
AI dossier — public-source company profileCytek Biosciences is a publicly traded (NASDAQ: CTKB, since 2021) biotechnology company headquartered in Fremont, California, that develops and manufactures full-spectrum flow cytometry instruments, reagents, and software used by researchers and clinicians worldwide. Its product portfolio includes the Aurora, Northern Lights, and Orion instrument families, along with proprietary reagents and cloud-based analysis software. The company serves applications in immuno-oncology, infectious disease, leukemia and lymphoma diagnosis, and transplant monitoring.
- Industry
- Biotechnology — Flow Cytometry Instruments & Life Science Tools
- Address
- 47215 Lakeview Blvd, Fremont, California 94538, US
- Employees
- 201-500
- Founded
- 2014
Attack summary
Severity: critical — 7.36 TB of data has been published from a NASDAQ-listed healthcare/biotech company operating in clinical diagnostics (leukemia, lymphoma, transplant monitoring). The scale of exfiltration and the company's involvement in clinical applications strongly implies regulated data (patient-adjacent clinical data, PII, financial records) is at risk at significant volume.The group cmdorganization claims to have exfiltrated 7.36 TB of data from Cytek Biosciences; the disclosure status is listed as data_published, indicating the stolen data has been released or made available. No ransom amount was stated.
Data the group says was taken
AI dossier — extracted from the leak post- Exfiltrated corporate data (7.36 TB)
- Potentially proprietary R&D and instrument design data
- Potentially customer and clinical researcher records
- Potentially financial and business records
- Potentially employee PII
What the group claims
A biotechnology firm that develops and supplies advanced, cost-effective flow cytometry instruments and related services used worldwide by researchers and clinicians. Its compact systems and streamlined workflows enable high-throughput, single-cell analysis for applications such as cancer immunology, leukemia and lymphoma diagnosis, and transplant monitoring. Distinguished by offering high-end capabilities at lower cost, the company accelerates scientific discovery through technical innovation, exceptional customer support, and a commitment to ethical practices and community engagement. Headquartered in Fremont, California, it has been publicly traded on NASDAQ since 2021. We have 7.36 TB of downloaded data.
Sources
- Victim sitecytekbio.com
Source
Indexed 19 days agoThis page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.
